Compounded Semaglutide & Tirzepatide — physician-prescribed, meticulously dosed, and delivered directly to your door.
Semaglutide is a GLP-1 (glucagon-like peptide-1) receptor agonist originally developed for type 2 diabetes management. At higher doses, it produces significant and sustained weight loss by acting on appetite-regulating centers in the brain, slowing gastric emptying, and improving insulin sensitivity.
Our compounded Semaglutide contains the same active ingredient as brand-name Wegovy® and Ozempic®, prepared by a US-licensed 503A or 503B pharmacy. Compounded versions allow for precise dose titration and more accessible pricing.
All patients undergo a comprehensive medical intake and provider review before starting. We use a slow, structured dose escalation protocol to minimize GI side effects and maximize tolerability and long-term results.
Clinical trials demonstrate average body weight reductions of 15–20% over 68 weeks — more than any previous non-surgical intervention.
Semaglutide acts on hypothalamic GLP-1 receptors to reduce hunger signals and increase satiety, making it significantly easier to maintain a caloric deficit.
Improves insulin sensitivity and reduces fasting glucose — clinically beneficial for pre-diabetic and diabetic patients.
The SUSTAIN-6 trial showed a 26% reduction in major adverse cardiovascular events in high-risk patients.
Beyond weight loss, Semaglutide improves lipid panels, reduces blood pressure, and decreases inflammatory markers.
Unlike crash diets, GLP-1 therapy recalibrates your body's weight set-point, supporting long-term maintenance of results.
Complete health history form. Our provider reviews your BMI, medical history, and goals.
Licensed provider determines candidacy and prescribes appropriate starting dose and escalation schedule.
Prescription sent to our partner pharmacy. Medication ships to your door in 3–5 business days.
Monthly check-ins, dose adjustments based on response and tolerability, and lab monitoring throughout.
Slow titration minimizes nausea and GI side effects.
Weekly subcutaneous injection, self-administered in abdomen, thigh, or upper arm. Syringes and instructions included. Most patients are comfortable after the first injection.
Common: nausea, reduced appetite, mild GI discomfort (usually resolves within 2–4 weeks). Tips: eat smaller meals, avoid high-fat foods, stay hydrated, inject before bed to sleep through nausea.